Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev. 2012;248:87–103.
Article
PubMed
PubMed Central
Google Scholar
Hofker MH, Fu J, Wijmenga C. The genome revolution and its role in understanding complex diseases. Biochim Biophys Acta. 2014;1842:1889–95.
Article
CAS
PubMed
Google Scholar
Goodin DS. The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities. BMC Neurol. 2016;16:56.
Article
PubMed
PubMed Central
CAS
Google Scholar
Goodin DS. The Genetic and Environmental Bases of Complex Human-Disease: Extending the Utility of Twin-Studies. PLoS ONE. 2012;7(12):e47875.
Article
CAS
PubMed
PubMed Central
Google Scholar
GAMES, the Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol. 2003;2003(143):39–46.
Google Scholar
de Bakker PIW, Yelensky R, Peer I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217–23.
Article
PubMed
CAS
Google Scholar
Herrera BM, Cader MZ, Dyment DA, Bell JT, Deluca GC, Willer CJ, Lincoln MR, Ramagopalan SV, Chao M, Orton SM, Sadovnick AD, Ebers GC. Multiple sclerosis susceptibility and the X chromosome. Mult Scler. 2007;13:856–8.
Article
CAS
PubMed
Google Scholar
The Wellcome Trust Case Control Consortium & The Australo-Anglo-American Spondylitis Consortium. Associations can of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genet. 2007;39:1329–37.
Article
CAS
Google Scholar
Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009;18:767–78.
Article
CAS
PubMed
Google Scholar
De Jager PL, Jia X, Wang J, de Bakkar PIW, Ottobani L, Aggarwal NT, Piccio L, Raychadhuri S, Dong T, Aubin C, Briskin R, Romano S, the International MS Genetics Consortium. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genet. 2009;41:776–82.
Article
PubMed
CAS
Google Scholar
Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, Murru R, Whalen MB, Busonaro F, Maschio A, Costa G, Melis CM, Deidda F, Poddie F, Morelli L, Farina G, Li Y, Dei M, Zavattari P, Moi L, Deriu E, Urru MF, Bajorek M, Satta MA, Cocco E, Ferringo P, Sotgiu S, Pugliatti M, Traccis S, Angius A, Melis M, Rosati G, Abacasis GR, Uda M, Marrosu GM, Schlessinger D, Cucca F. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet. 2010;42:495–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
The International Multiple Sclerosis Genetics Consortium & the Wellcome Trust Case Control Consortium. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214–9.
Article
CAS
Google Scholar
International Multiple Sclerosis Genetics Consortium (IMSGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2014;45:1353–60.
Article
CAS
Google Scholar
International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;65:eaav7188.
Article
CAS
Google Scholar
Dyment DA, Herrera BM, Cader Z, Willer CJ, Lincoln MR, Sadovnock AD, Risch N, Ebers GC. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet. 2005;14:2019–26.
Article
CAS
PubMed
Google Scholar
Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakkar PIW, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcelloos LF, Cree B, Oksenberg JR, Hauser SL. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357:851–62.
Article
CAS
PubMed
Google Scholar
Ramagopalan SV, Anderson C, Sadovnick AD, Ebers GC. Genomewide study of multiple sclerosis. N Engl J Med. 2007;357:2199–200.
Article
CAS
PubMed
Google Scholar
Link J, Kockum I, Lorentzen AR, Lie BA, Celius EG, Westerlind H, Schaffer M, Alfredsson L, Olsson T, Brynedal B, Harbo HF, Hillert J. Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis. PLoS ONE. 2012;7(5):e36779.
Article
CAS
PubMed
PubMed Central
Google Scholar
Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Diujn CM, Nobel JA, Raj T, IMSGC, ANZgene, Gourraud PA, Stranger BE, Oksenberg J, Olsson T, Taylor BV, Saucer S, Hafler DA, Carrington M, De Jager PL, de Bakkar PIW. Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects. PLoS Genet. 2014; 9(11):e1003926.
Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Montpetit A, Sadovnick AD, Knight JC, Ebers GC. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci USA. 2008;105:13069–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA. 2009;106:7542–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Multiple Sclerosis Genetics Group. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Molec Genet. 1998;7:1229–34.
Article
Google Scholar
Goodin DS, Khankhanian P. Single nucleotide polymorphism (SNP)-strings: an alternative method for assessing genetic associations. PLoS ONE. 2014;9(4):e90034.
Article
PubMed
PubMed Central
CAS
Google Scholar
Khankhanian P, Gourraud PA, Lizee A, Goodin DS. Haplotype-based approach to known MS-associated regions increases the amount of explained risk. J Med Genet. 2015;52:587–94.
Article
CAS
PubMed
Google Scholar
Gragert L, Madbouly A, Freeman J, Maiers M. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum Immunol. 2013;74:1313–20.
Article
CAS
PubMed
Google Scholar
Goodin DS, Khankhanian P, Gourraud PA, Vince N. Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility. PLoS ONE. 2018;13(2):e0190043.
Article
PubMed
PubMed Central
CAS
Google Scholar
Siemiatycki J, Thomas DC. Biological models and statistical interactions: an example from multistage carcinogenesis. Int J Epidemiol. 1981;10:383–7.
Article
CAS
PubMed
Google Scholar
Xie T, Rowen L, Aquado B, Ahearn ME, Madan A, Qin S, Campbell RD, Hood L. Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res. 2003;134:2621–36.
Article
CAS
Google Scholar
Kodell RL, Gaylor DW. On the additive and multiplicative models of relative risk. Biometrical J. 1989;31:359–70.
Article
Google Scholar
Greenland S. Additive risk versus additive relative risk models. Epidemiology. 1993;4:32–6.
Article
CAS
PubMed
Google Scholar
Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott, Williams & Wilkins; 1998.
Google Scholar
van der Mei I, Lucas R, Taylor B, Valery PC, Dwyer T, Kilpatrick TJ, Pender MP, Williams D, Chapman C, Otahal P, Ponsonby AL. Population attributable fractions and joint effects of key risk factors for multiple sclerosis. Mult Scler J. 2016;22:461–9.
Article
CAS
Google Scholar
De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Simon C, Aubin C, Bauer D, Heubach JF, Sandbrink R, Tyblova M, Lelkova P, Steering Committie of the BENEFIT Study, Steering Committie of the BEYOND Study, Steering Committie of the LTF Study, Steering Committie of the CCR1 Study, Hardova E, Pohl C, Horakova D, Ascherio A, Hafler DA, Karlson EW. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility. Lancet Neurol. 2009;8:1111–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, Oksenberg JR. Aggregation of MS genetic risk variants in multiple and single case families. Ann Neurol. 2011;69:65–74.
Article
PubMed
PubMed Central
Google Scholar
Isobe N, Damotte V, Lo Re V, Ban M, Pappas D, Guillot-Noel RI, Compston A, Mack T, Cozen W, Fontaine B, Hauser SL, Oksenberg JR, Sawcer S, Gouraud PA. Genetic Burden in multiple sclerosis families. Genes Immunity. 2013;14:434–40.
Article
CAS
PubMed
Google Scholar
Goodin DS, Khankhanian P, Gourraud PA, Vince N. The nature of genetic and environmental susceptibility to Multiple Sclerosis. PLoS ONE. 2021;16(3):6157.
Article
CAS
Google Scholar
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227–31.
Article
CAS
PubMed
Google Scholar
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–7.
Article
CAS
PubMed
Google Scholar
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol. 2005;58:840–6.
Article
PubMed
Google Scholar
Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR, Weir BS. HIBAG-HLA genotype imputation with attribute bagging. Pharmacogenom J. 2014;14:192–200.
Article
CAS
Google Scholar
Okada Y, Momozawa Y, Ashikawa K, Kanai M, Matsuda K, Kamatani Y, Takahashi A, Kubo M. Construction of a population-specific HLA imputation reference panel and its application to Graves’disease risk in Japanese. Nat Genet. 2015;47:798–802.
Article
CAS
PubMed
Google Scholar
Karnes JH, Shaffer CM, Bastarache L, Gaudieri S, Glazer AM, Steiner HE, Mosley JD, Mallal S, Denny JC, Phillips EJ, Roden DM. Comparison of HLA allelic imputation programs. PLoS ONE. 2017;12:e0172444.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gourraud PA, Lamiraux P, El-Kadhi N, Raffoux C, Cambon-Thompsen A. Inferred HLA haplotype information for donors from hematopoietic stem cells donor registries. Hum Immunol. 2005;66:563–70.
Article
CAS
PubMed
Google Scholar
Gourraud PA, Khankhanian P, Cereb N, Yang SY, Feolo M, Maiers M, Rioux JD, Hauser S, Oksenberg. HLA diversity in the 1000 genomes dataset. PLoS ONE. 2014;9:e9782.
Article
CAS
Google Scholar
Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289–30037.
Google Scholar
Viera AJ. Odds ratios and risk ratios: What’s the difference and why does it matter? South Med J. 2008;101:730–4.
Article
PubMed
Google Scholar
Goodin DS. The causal cascade to multiple sclerosis: A model for MS pathogenesis. PLoS ONE. 2009;4(2):e4565.
Article
PubMed
PubMed Central
CAS
Google Scholar
Goodin DS. The epidemiology of multiple sclerosis: Insights to a causal cascade. Handb Clin Neurol. 2016;138:173–206.
Article
CAS
PubMed
Google Scholar
Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61:288–99.
Article
PubMed
Google Scholar
Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol. 2007;61:504–13.
Article
CAS
PubMed
Google Scholar
Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010;2010(9):599–612.
Article
Google Scholar
Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs rare allele hypotheses for complex diseases. Curr Opin Genet Dev. 2009;19:212–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Roux T, Courtillot C, Debs R, Touraine P, Lubetzki C, Papeix C. Fecundity in women with multiple sclerosis: an observational mono-centric study. J Neurol. 2015;262:957–60.
Article
PubMed
Google Scholar